Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 07 2019
Historique:
received: 19 02 2019
accepted: 04 07 2019
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 21 10 2020
Statut: epublish

Résumé

Herbal-based dietary supplements have become increasingly popular. The extract from milk thistle (Silybum marianum), is often used for the treatment of liver diseases. However, serious concerns exist regarding the efficacy, composition, as well as the safety of these over-the-counter preparations. Therefore, the aim of the present study was to investigate the composition as well as chemical and biological safety of 26 milk thistle-based dietary supplements purchased from both the U.S. and Czech markets between 2016 and 2017. The study was focused on a determination of the composition of active ingredients, as well as analyses of possible contaminants including: mycotoxins, plant alkaloids, and pesticide residues, as well as the microbial purity. High-throughput analyses were performed using advanced U-HPLC-HRMS techniques. Large differences in the silymarin content were observed among individual milk thistle preparations, often in contrast with the information provided by the manufacturers. In addition, substantial inter-batch differences in silymarin content were also demonstrated. In all milk thistle preparations tested, large numbers and high concentrations of mycotoxins and several pesticides, as well as the substantial presence of microbiological contamination were detected, pointing to serious safety issues. In conclusion, our results strongly indicate the need for strict controls of the composition, chemical contaminants, as well as the microbiological purity of commercial milk thistle extracts used for the treatment of liver diseases. Poor definition of these preparations together with contamination by biologically active substances may not only account for the inconsistency of clinical observations, but also be responsible for possible herbal-based dietary supplements-induced liver injury.

Identifiants

pubmed: 31366891
doi: 10.1038/s41598-019-47250-0
pii: 10.1038/s41598-019-47250-0
pmc: PMC6668463
doi:

Substances chimiques

Antioxidants 0
Biological Products 0
Mycotoxins 0
Pesticides 0
Plant Extracts 0
Silymarin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11118

Références

JAMA. 2012 Jul 18;308(3):274-82
pubmed: 22797645
J Chromatogr A. 2013 Mar 22;1282:11-9
pubmed: 23415469
J Nutr. 2011 Feb;141(2):261-6
pubmed: 21178089
Pharmacol Res. 2003 Jan;47(1):17-26
pubmed: 12526857
Food Res Int. 2017 Oct;100(Pt 3):339-353
pubmed: 28964357
Integr Cancer Ther. 2015 Jan;14(1):35-41
pubmed: 25228537
Mycobiology. 2017 Dec;45(4):240-254
pubmed: 29371792
J Pharm Biomed Anal. 2017 Sep 5;143:204-213
pubmed: 28605682
Hepatology. 2017 Jan;65(1):363-373
pubmed: 27677775
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(6):994-9
pubmed: 22439650
Sci Total Environ. 2016 Feb 15;544:507-14
pubmed: 26674679
Food Chem. 2015 Jul 1;178:136-48
pubmed: 25704694
Semin Liver Dis. 2018 Feb;38(1):21-40
pubmed: 29471563
Gastroenterology. 2008 Nov;135(5):1561-7
pubmed: 18771667
Pathog Dis. 2013 Feb;67(1):25-38
pubmed: 23620117
Int J Food Microbiol. 2013 Jun 3;164(1):87-91
pubmed: 23624536
Biomed Res Int. 2014;2014:941085
pubmed: 25247194
J Clin Oncol. 2004 Feb 1;22(3):517-28
pubmed: 14752075
Org Biomol Chem. 2003 May 21;1(10):1684-9
pubmed: 12926355
Oxid Med Cell Longev. 2019 Feb 12;2019:6026902
pubmed: 30891115
J Agric Food Chem. 2015 Jul 29;63(29):6633-43
pubmed: 26168136
Saudi Pharm J. 2019 Feb;27(2):240-245
pubmed: 30766436
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2018 Jan;35(1):118-133
pubmed: 28942718
Curr Pharm Biotechnol. 2012 Jan;13(1):210-7
pubmed: 21466434
Gastroenterology. 2015 Mar;148(3):517-532.e3
pubmed: 25500423
Fitoterapia. 2011 Jan;82(1):44-52
pubmed: 20884340
Oncol Res. 2005;15(5):281-9
pubmed: 16261847
Carcinogenesis. 2010 Jan;31(1):71-82
pubmed: 19875698
World J Gastroenterol. 2017 Jul 21;23(27):5004-5017
pubmed: 28785154
Food Chem Toxicol. 2017 Nov;109(Pt 1):439-451
pubmed: 28935499
J Clin Oncol. 2008 Feb 1;26(4):665-73
pubmed: 18235127
Medicine (Baltimore). 2017 Dec;96(49):e9061
pubmed: 29245314
J Chromatogr Sci. 2015 Feb;53(2):366-72
pubmed: 24895445
J Mass Spectrom. 2016 Sep;51(9):729-41
pubmed: 27502171
Am J Gastroenterol. 2014 Jul;109(7):950-66; quiz 967
pubmed: 24935270
Natl Health Stat Report. 2008 Dec 10;(12):1-23
pubmed: 19361005
Free Radic Biol Med. 2017 Feb;103:256-267
pubmed: 28039083
Drug Test Anal. 2016 Mar-Apr;8(3-4):418-23
pubmed: 26857794
Toxins (Basel). 2017 Dec 22;10(1):
pubmed: 29271890
Food Chem Toxicol. 2007 Jan;45(1):1-18
pubmed: 17045381
Toxicol Appl Pharmacol. 2013 Oct 1;272(1):191-8
pubmed: 23735874
Environ Toxicol. 2017 May;32(5):1658-1664
pubmed: 27628925
NCHS Data Brief. 2011 Apr;(61):1-8
pubmed: 21592424
Hepatology. 2000 Aug;32(2):442-4
pubmed: 10960282
Anal Chim Acta. 2015 Mar 10;863:29-40
pubmed: 25732310
J Agric Food Chem. 2016 Aug 10;64(31):6125-32
pubmed: 27101866
Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007749
pubmed: 21412909

Auteurs

Marie Fenclova (M)

Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.

Alena Novakova (A)

Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.

Jitka Viktorova (J)

Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.

Petra Jonatova (P)

Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.

Zbynek Dzuman (Z)

Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.

Tomas Ruml (T)

Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.

Vladimir Kren (V)

Laboratory of Biotransformation, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1082, 14000, Prague 6, Czech Republic.

Jana Hajslova (J)

Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic.

Libor Vitek (L)

Institute of Medical Biochemistry and Laboratory Diagnostics and 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Katerinska 32, 12108, Prague 2, Czech Republic. vitek@cesnet.cz.

Milena Stranska-Zachariasova (M)

Department of Food Analysis and Nutrition, University of Chemistry and Technology, Technicka 3, 16628, Prague 6, Czech Republic. milena.stranska@vscht.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH